Experience

Throne Biotechnologies

• United States
• Biotechnology Research
• 1 - 100 Employee

• Founder and CEO

  • Jan 2011 - Present

  Throne's Stem Cell Educator Therapy is a one-time dialysis-like treatment that resets the immune system, thereby fundamentally reversing diabetes, alopecia areata, and other autoimmune diseases. This technology uses a new type of stem cell (CB-SC) discovered and patented by Throne's lab. This FDA phase 2 approved technology has been recognized by the Juvenile Diabetes Cure Alliance as one of the top 7 “Practical Cure Projects” for type 1 diabetes out of 594 global technologies. Throne is currently undergoing clinical trials for 3 FDA phase 2 approved INDs (type 1 diabetes, alopecia areata, COVID-19). Currently raising $5M series A to complete FDA phase 2 clinical trials through to commercialization within 2-3 years.



Center for Discovery and Innovation

• United States
• Research
• 1 - 100 Employee

• Associate Scientist, Principle Investigator

  • 2019 - Jul 2021



Seton Hall University

• United States
• Higher Education
• 700 & Above Employee

• Associate Professor

  • 2017 - Jul 2021



Hackensack Meridian School of Medicine

• United States
• Higher Education
• 100 - 200 Employee

• Associate Professor

  • 2017 - 2019



Hackensack Meridian Health

• United States
• Hospitals and Health Care
• 700 & Above Employee

• Associated Scientist

  • 2013 - 2018



University of Illinois Chicago

• United States
• Higher Education
• 700 & Above Employee

• Assistant Professor

  • 2004 - 2012



University of Chicago

• United States
• Higher Education
• 700 & Above Employee

• Postdoctoral Researcher

  • 2000 - 2004



Qianfoshan Hospital

• Shandong, China

• Attending Doctor

  • 1995 - 1997



Qihe People Hospital - Department of Internal Medicine

• Shandong, China

• Physician - Residency

  • 1991 - 1992